GLP-1 release and vagal afferent activation mediate the beneficial metabolic and chronotherapeutic effects of D-allulose
The sweetener D-allulose has beneficial metabolic effects in animal models, but its mechanism of action was unclear. Here the authors report that D-allulose triggers GLP-1 release in the gut and GLP-1R signaling on vagal afferents, counteracting arrhythmic overeating, obesity and diabetes.
Guardado en:
Autores principales: | Yusaku Iwasaki, Mio Sendo, Katsuya Dezaki, Tohru Hira, Takehiro Sato, Masanori Nakata, Chayon Goswami, Ryohei Aoki, Takeshi Arai, Parmila Kumari, Masaki Hayakawa, Chiaki Masuda, Takashi Okada, Hiroshi Hara, Daniel J. Drucker, Yuichiro Yamada, Masaaki Tokuda, Toshihiko Yada |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2018
|
Materias: | |
Acceso en línea: | https://doaj.org/article/e12ee17a7b5b43b1bfe21f19dd080e2a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Comparative pharmacology of cholecystokinin induced activation of cultured vagal afferent neurons from rats and mice.
por: Dallas C Kinch, et al.
Publicado: (2012) -
The effect of transcutaneous auricular vagal nerve stimulation on short latency afferent inhibition and cerebello-cortical inhibition – indirect TMS measures of the activity of the basal cholinergic system and the inhibitory Purkinje cell activity
por: Vesna van Midden, et al.
Publicado: (2021) -
Vagal determinants of exercise capacity
por: Asif Machhada, et al.
Publicado: (2017) -
Effects of GLP-1 receptor agonist on changes in the gut bacterium and the underlying mechanisms
por: Shunsuke Kato, et al.
Publicado: (2021) -
Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice
por: Mette Simone Aae Madsen, et al.
Publicado: (2019)